Orca1
Involved In Discussions
Interview Question
If you have three non-conformances to deal with. How would you prioritize them? Which one will you work on first?
By consideration of the following factors:
- Risk to patient or user: Non-conformances that pose a significant risk to the patient or user should be addressed first. This includes unresolved product non-conformances that could lead to recalls if not resolved (FDA QSIT, Purpose/Importance, 160).
- Impact on product quality: Non-conformances that directly affect product quality and compliance with specifications should be prioritized (21 CFR 820.100(a)(2)).
- Recurrence and trends: Non-conformances that are recurring or show a trend of increasing frequency should be addressed promptly to prevent further issues (21 CFR 820.100(a)(1)).
- Regulatory implications: Non-conformances that may result in regulatory actions, such as Warning Letters or enforcement actions, should be prioritized (FDA CP 7382.845, A. QUALITY SYSTEM REGULATORY/ADMINISTRATIVE FOLLOW-UP, 378).
Based on these, prioritize the non-conformances and address the most critical ones first.